Kangfang Biological (09926.HK) released its interim financial results, with a gross profit of 1.121 billion yuan, an increase of 18.82% year-on-year.

Globe news from Wisdom Finance APP, Kangfang Biotech (09926.HK) released its interim results for the six months ending June 30, 2025, with revenue of 1.412 billion yuan, an increase of 37.75% year-on-year; gross profit of 1.121 billion yuan, an increase of 18.82% year-on-year; research and development expenses of 731 million yuan, an increase of 23.02% year-on-year.